References
- 1. Bonawitz SC. Management of exposure of cardiac pacemaker systems. Ann Plast Surg 2012; 69: 292-295. doi: 10.1097/SAP.0b013e31822350cc10.1097/SAP.0b013e31822350cc
- 2. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 to 2004: a population-based analysis. J Gen Intern Med 2008; 23 Suppl 1: 13-19. doi: 10.1007/s11606-007-0392-010.1007/s11606-007-0392-0
- 3. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol 2012; 60: 1540-1545. doi: 10.1016/j.jacc.2012.07.01710.1016/j.jacc.2012.07.017
- 4. Koutentakis M, Siminelakis S, Korantzopoulos P, Petrou A, Priavali H, Mpakas A, et al. Surgical management of cardiac implantable electronic device infections. J Thorac Dis 2014; 6 Suppl 1: S173-179. doi: 10.3978/j.issn.2072-1439.2013.10.2310.3978/j.issn.2072-1439.2013.10.23
- 5. Conklin EF, Giannelli S Jr, Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg 1975; 69: 1-710.1016/S0022-5223(19)41605-X
- 6. Bluhm G. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand Suppl 1985; 699: 1-62
- 7. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49: 1851-1859. doi: 10.1016/j.jacc.2007.01.07210.1016/j.jacc.2007.01.072
- 8. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010; 121: 458-477. doi: 10.1161/CIRCULATIONAHA.109.19266510.1161/CIRCULATIONAHA.109.192665
- 9. Uslan DZ, Sohail MR, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis 2006; 43: 731-736. doi: 10.1086/50694210.1086/506942
- 10. Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI, et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med 2005; 118: 1416. doi: 10.1016/j.amjmed.2005.06.01116378797
- 11. Smith HJ, Fearnot NE, Byrd CL, Wilkoff BL, Love CJ, Sellers TD. Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. Pacing Clin Electrophysiol 1994; 17: 2016-202010.1111/j.1540-8159.1994.tb03792.x
- 12. Hesselvik JF, Ortega RA. Simultaneous transesophageal atrial pacing and transesophageal echocardiography in cardiac surgical patients. J Cardiothorac Vasc Anesth 1998; 12: 281-283963690810.1016/S1053-0770(98)90006-4
- 13. Braun MU, Rauwolf T, Bock M, Kappert U, Boscheri A, Schnabel A, et al. Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection – a prospective and controlled study. Pacing Clin Electrophysiol 2006; 29: 875-879. doi: 10.1111/j.1540-8159.2006.00454.x10.1111/j.1540-8159.2006.00454.x16923004
- 14. Mathur G, Stables RH, Heaven D, Ingram A, Sutton R. Permanent pacemaker implantation via the femoral vein: an alternative in cases with contraindications to the pectoral approach. Europace 2001; 3: 56-59. doi: 10.1053/eupc.2000.013510.1053/eupc.2000.013511271953
- 15. Chew DS, Kuriachan V. Leadless cardiac pacemakers: present and the future. Curr Opin Cardiol 2018; 33: 7-13. doi: 10.1097/HCO.000000000000046810.1097/HCO.000000000000046829045345